Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Denizot

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Leukemia Research|June 20, 2008
5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blastsChristelle Vincent, Rémi Fiancette, Magali Donnard, et al.
Journal of Cardiothoracic Surgery|September 25, 2007
Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgeryYves Denizot, Alexandre Leguyader, Elisabeth Cornu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotypeVéronique Truffinet, Eric Pinaud, Nadine Cogné, et al.
Biochimica Et Biophysica Acta|November 26, 2008
Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphomaChristelle Vincent, Véronique Truffinet, Remi Fiancette, et al.
Blood|June 12, 2010
Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypesChristelle Vincent-Fabert, Remi Fiancette, Eric Pinaud, et al.
Oncotarget|May 18, 2012
Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular originPauline Rouaud, Rémi Fiancette, Christelle Vincent-Fabert, et al.
Leukemia Research|December 19, 2009
A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignanciesRémi Fiancette, Rada Amin, Véronique Truffinet, et al.
Advances in Immunology|July 19, 2011
The IgH locus 3' regulatory region: pulling the strings from behindEric Pinaud, Marie Marquet, Rémi Fiancette, et al.
Blood Advances|January 4, 2020
Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomasNour Ghazzaui, Hussein Issaoui, Mélissa Ferrad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgeneRémi Fiancette, Pauline Rouaud, Christelle Vincent-Fabert, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Leukemia Research|June 20, 2008
5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blastsChristelle Vincent, Rémi Fiancette, Magali Donnard, et al.
Journal of Cardiothoracic Surgery|September 25, 2007
Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgeryYves Denizot, Alexandre Leguyader, Elisabeth Cornu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotypeVéronique Truffinet, Eric Pinaud, Nadine Cogné, et al.
Biochimica Et Biophysica Acta|November 26, 2008
Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphomaChristelle Vincent, Véronique Truffinet, Remi Fiancette, et al.
Blood|June 12, 2010
Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypesChristelle Vincent-Fabert, Remi Fiancette, Eric Pinaud, et al.
Oncotarget|May 18, 2012
Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular originPauline Rouaud, Rémi Fiancette, Christelle Vincent-Fabert, et al.
Leukemia Research|December 19, 2009
A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignanciesRémi Fiancette, Rada Amin, Véronique Truffinet, et al.
Advances in Immunology|July 19, 2011
The IgH locus 3' regulatory region: pulling the strings from behindEric Pinaud, Marie Marquet, Rémi Fiancette, et al.
Blood Advances|January 4, 2020
Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomasNour Ghazzaui, Hussein Issaoui, Mélissa Ferrad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgeneRémi Fiancette, Pauline Rouaud, Christelle Vincent-Fabert, et al.
Pageof 7